PetMed Express, Inc. (PETS) financial statements (2021 and earlier)

Company profile

Business Address 420 SOUTH CONGRESS AVENUE
DELRAY BEACH, FL 33445
State of Incorp. FL
Fiscal Year End March 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments921017859385134
Cash and cash equivalents921017859383618
Short-term investments     1616
Receivables2322222
Inventory, net of allowances, customer advances and progress billings (0)(0)(0)(0)(0)36
Inventory (0)(0)(0)(0)(0)36
Prepaid expense 11 0 0
Other undisclosed current assets2823242128273
Total current assets:12312610582688074
Noncurrent Assets
Property, plant and equipment262729302121
Intangible assets, net (including goodwill)1111111
Intangible assets, net (excluding goodwill)1111111
Prepaid expense      2
Other undisclosed noncurrent assets    10 
Total noncurrent assets:272830312324
TOTAL ASSETS:150154135113908378
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18181718776
Accounts payable17161515556
Accrued liabilities 01000 
Employee-related liabilities 11101 
Taxes payable1001010
Interest and dividends payable 00000 
Other undisclosed current liabilities3111 02
Total current liabilities:21191818778
Noncurrent Liabilities
Liabilities, other than long-term debt      0
Deferred tax liabilities, net     0
Other undisclosed noncurrent liabilities1111   
Total noncurrent liabilities:1111  0
Other undisclosed liabilities    1  
Total liabilities:22201919778
Stockholders' equity
Stockholders' equity attributable to parent12813511693837570
Preferred stock0000000
Common stock0000000
Additional paid in capital31297532
Accumulated other comprehensive loss     (0)(0)
Retained earnings12512210687787269
Total stockholders' equity:12813511693837570
TOTAL LIABILITIES AND EQUITY:150154135113908378

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues274283274249235229233
Revenue, net 249235229233
Cost of revenue(194)(188)(176)(170)(158)(153)(156)
Cost of goods and services sold(194)(188) (170)(158)(153)(156)
Gross profit:80959879767678
Operating expenses(50)(49)(46)(42)(44)(49)(49)
Operating income:30465237322828
Nonoperating income3320000
Investment income, nonoperating2210000
Other nonoperating income (expense)111000(0)
Income from continuing operations before income taxes:33495438332828
Income tax expense(8)(11)(17)(14)(12)(10)(10)
Net income available to common stockholders, diluted:25383724211718

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net income:25383724211718
Comprehensive income:25383724211718
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    0(0)(0)
Comprehensive income, net of tax, attributable to parent:25383724211718

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: